177 related articles for article (PubMed ID: 17613656)
1. New cyclodextrin bioconjugates for active tumour targeting.
Salmaso S; Bersani S; Semenzato A; Caliceti P
J Drug Target; 2007 Jul; 15(6):379-90. PubMed ID: 17613656
[TBL] [Abstract][Full Text] [Related]
2. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery.
Caliceti P; Salmaso S; Semenzato A; Carofiglio T; Fornasier R; Fermeglia M; Ferrone M; Pricl S
Bioconjug Chem; 2003; 14(5):899-908. PubMed ID: 13129392
[TBL] [Abstract][Full Text] [Related]
4. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
5. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
6. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
7. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
9. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
10. Assembling of stimuli-responsive tumor targeting polypyrrole nanotubes drug carrier system for controlled release.
Chen J; Li X; Li J; Li J; Huang L; Ren T; Yang X; Zhong S
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():316-327. PubMed ID: 29752103
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
12. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
[TBL] [Abstract][Full Text] [Related]
14. Folic-Acid-Targeted Self-Assembling Supramolecular Carrier for Gene Delivery.
Liao R; Yi S; Liu M; Jin W; Yang B
Chembiochem; 2015 Jul; 16(11):1622-8. PubMed ID: 26032689
[TBL] [Abstract][Full Text] [Related]
15. Curcumin loaded β-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment.
Einafshar E; Javid H; Amiri H; Akbari-Zadeh H; Hashemy SI
Carbohydr Polym; 2024 Sep; 340():122328. PubMed ID: 38857995
[TBL] [Abstract][Full Text] [Related]
16. Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells.
Pillai JJ; Thulasidasan AK; Anto RJ; Chithralekha DN; Narayanan A; Kumar GS
J Nanobiotechnology; 2014 Jul; 12():25. PubMed ID: 25026938
[TBL] [Abstract][Full Text] [Related]
17. Folate-PEG/Hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
Le TT; Kim D
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
[TBL] [Abstract][Full Text] [Related]
18. Y-shaped Folic Acid-Conjugated PEG-PCL Copolymeric Micelles for Delivery of Curcumin.
Feng R; Zhu W; Chu W; Teng F; Meng N; Deng P; Song Z
Anticancer Agents Med Chem; 2017; 17(4):599-607. PubMed ID: 27528180
[TBL] [Abstract][Full Text] [Related]
19. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor.
Movileanu C; Anghelache M; Turtoi M; Voicu G; Neacsu IA; Ficai D; Trusca R; Oprea O; Ficai A; Andronescu E; Calin M
Int J Pharm; 2022 Sep; 625():122064. PubMed ID: 35952802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
